Sino Biopharmaceutical (FRA:SMZ1) Operating Cash Flow per Share : €0.05 (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Sino Biopharmaceutical Operating Cash Flow per Share?

Sino Biopharmaceutical's operating cash flow per share for the six months ended in Dec. 2024 was €0.03. Sino Biopharmaceutical's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.05.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sino Biopharmaceutical was 8.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Sino Biopharmaceutical's Operating Cash Flow per Share or its related term are showing as below:

FRA:SMZ1' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -31.2 Med: 15.3 Max: 77.8
Current: 4.2

During the past 13 years, Sino Biopharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 77.80% per year. The lowest was -31.20% per year. And the median was 15.30% per year.

FRA:SMZ1's 3-Year OCF Growth Rate is ranked worse than
55.45% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs FRA:SMZ1: 4.20

Sino Biopharmaceutical Operating Cash Flow per Share Historical Data

The historical data trend for Sino Biopharmaceutical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Operating Cash Flow per Share Chart

Sino Biopharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.04

0.05

0.04

0.05

Sino Biopharmaceutical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.03

Competitive Comparison of Sino Biopharmaceutical's Operating Cash Flow per Share

For the Biotechnology subindustry, Sino Biopharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Sino Biopharmaceutical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Sino Biopharmaceutical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	867.697	/	18295.060
	=	0.05

Sino Biopharmaceutical's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	463.895	/	18181.818
	=	0.03

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.05

Sino Biopharmaceutical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (FRA:SMZ1) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA 01177:Hong Kong

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2024, 41.8% of the firm's total revenue comes from its innovative product category, which includes innovative drugs and biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 37.2% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

Sino Biopharmaceutical Headlines

No Headlines